SARA HOPPER: Open Payments
NPI 1972054807 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,818 in 126 payments from 18 companies in 2025. Trend: 2023 $4,273 · 2024 $6,113 · 2025 $2,818
Food & beverage: $2,718Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $384 |
| Regeneron Healthcare Solutions, Inc. | 10 | $339 |
| Novartis Pharmaceuticals Corporation | 15 | $336 |
| LEO Pharma Inc. | 10 | $335 |
| Organon LLC | 10 | $237 |
| UCB, Inc. | 12 | $192 |
| PFIZER INC. | 12 | $187 |
| Janssen Biotech, Inc. | 7 | $164 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $152 |
| GENZYME CORPORATION | 1 | $92 |
Products named: DUPIXENT, COSENTYX, RINVOQ, Bimzelx, CIBINQO, ANZUPGO, TREMFYA, ADBRY.
Industry payments across AL — which companies pay providers there.
